4//SEC Filing
HOBDEN ADRIAN N 4
Accession 0001191076-09-000006
CIK 0000899923other
Filed
May 28, 8:00 PM ET
Accepted
May 29, 3:58 PM ET
Size
8.2 KB
Accession
0001191076-09-000006
Insider Transaction Report
Form 4
HOBDEN ADRIAN N
Pres. Myriad Pharmaceuticals
Transactions
- Exercise/Conversion
Common Stock
2009-05-27$2.39/sh+40,000$95,620→ 235,726 total - Sale
Common Stock
2009-05-27$34.01/sh−40,000$1,360,568→ 195,726 total - Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2009-05-27−40,000→ 0 totalExercise: $2.39Exp: 2009-06-17→ Common Stock (40,000 underlying)
Footnotes (1)
- [F1]20% vests annually beginning on the 1st anniversary of the date of the Option Grant.
Documents
Issuer
MYRIAD GENETICS INC
CIK 0000899923
Entity typeother
Related Parties
1- filerCIK 0001191076
Filing Metadata
- Form type
- 4
- Filed
- May 28, 8:00 PM ET
- Accepted
- May 29, 3:58 PM ET
- Size
- 8.2 KB